Analysts cut Ovintiv targets, maintain ratings
Truist Securities and Stephens & Co. lowered their price targets for Ovintiv to $66 and $68, respectively, while maintaining Buy and Equal-Weight ratings.
*this image is generated using AI for illustrative purposes only.
Truist Securities and Stephens & Co. have revised their price targets for Ovintiv, reflecting updated valuations while maintaining their respective ratings on the energy producer. Truist Securities analyst Gabe Daoud kept a Buy rating but lowered the target to $66 from $70. Separately, Stephens & Co. analyst Mike Scialla maintained an Equal-Weight rating and reduced the price target to $68 from $71.
Ovintiv is listed on the NYSE under the ticker symbol OVV. The adjustments from both firms indicate a recalibration of the stock's potential following recent market assessments.
| Firm | Analyst | Rating | Previous Target | New Target |
|---|---|---|---|---|
| Truist Securities | Gabe Daoud | Buy | $70 | $66 |
| Stephens & Co. | Mike Scialla | Equal-Weight | $71 | $68 |
What factors might drive further adjustments to Ovintiv's valuation in the coming months?
How could fluctuating energy prices impact Ovintiv's stock performance relative to these revised targets?
Will Ovintiv's operational efficiency or cost-cutting measures influence future analyst ratings?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
